PODXL and pancreatic ductal adenocarcinoma: To elucidate SIN3B's role in pancreatic ductal adenocarcinoma (PDAC), we employed CRISPR‐Cas9 to specifically knock out (KO) Sin3B in the murine PDAC cell line KPC1199, derived from KPC mouse model (Pdx‐cre, LSL‐KrasG12D, Trp53R172H).